Literature DB >> 2354140

Acute angle-closure glaucoma following botulinum toxin injection for blepharospasm.

P Corridan1, S Nightingale, N Mashoudi, A C Williams.   

Abstract

Botulinum toxin inhibits acetylcholine release and therefore could cause mydriasis. We report a case of acute angle-closure glaucoma which occurred shortly after a series of injections of botulinum toxin round the eyelids for blepharospasm.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2354140      PMCID： PMC1042106          DOI： 10.1136/bjo.74.5.309

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


  9 in total

1.  Selective block of synaptic transmission in ciliary ganglion by type A botulinus toxin in rabbits.

Authors:  C KUPFER
Journal:  Proc Soc Exp Biol Med       Date:  1958-11

2.  The peripheral action of Cl. botulinum toxin.

Authors:  N Ambache
Journal:  J Physiol       Date:  1949-03-15       Impact factor: 5.182

3.  Clostridium botulinum toxins: nature and preparation for clinical use.

Authors:  J Melling; P Hambleton; C C Shone
Journal:  Eye (Lond)       Date:  1988       Impact factor: 3.775

4.  Botulinum toxin therapy for involuntary facial movement.

Authors:  J S Elston
Journal:  Eye (Lond)       Date:  1988       Impact factor: 3.775

5.  Botulinum toxin A induced protective ptosis.

Authors:  G G Adams; C M Kirkness; J P Lee
Journal:  Eye (Lond)       Date:  1987       Impact factor: 3.775

6.  Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery.

Authors:  A B Scott
Journal:  Ophthalmology       Date:  1980-10       Impact factor: 12.079

7.  Primary angle-closure glaucoma. A review of provocative tests.

Authors:  R F Lowe
Journal:  Br J Ophthalmol       Date:  1967-11       Impact factor: 4.638

8.  Botulinum A toxin injection as a treatment for blepharospasm.

Authors:  A B Scott; R A Kennedy; H A Stubbs
Journal:  Arch Ophthalmol       Date:  1985-03

9.  Long-term results and complications of botulinum A toxin in the treatment of blepharospasm.

Authors:  J J Dutton; E G Buckley
Journal:  Ophthalmology       Date:  1988-11       Impact factor: 12.079
  9 in total
  9 in total

Review 1.  Non-steroidal drug-induced glaucoma.

Authors:  M R Razeghinejad; M J Pro; L J Katz
Journal:  Eye (Lond)       Date:  2011-06-03       Impact factor: 3.775

2.  Acute angle-closure glaucoma following botulinum toxin.

Authors: 
Journal:  Br J Ophthalmol       Date:  1991-06       Impact factor: 4.638

3.  Unilateral transient mydriasis and ptosis after botulinum toxin injection for a cosmetic procedure.

Authors:  Sezen Akkaya; Hatice Kübra Kökcen; Tuğba Atakan
Journal:  Clin Ophthalmol       Date:  2015-02-12

Review 4.  Use of Botulinum Neurotoxin in Ophthalmology.

Authors:  Emel Başar; Ceyhun Arıcı
Journal:  Turk J Ophthalmol       Date:  2016-12-01

Review 5.  Drug-induced Angle-Closure Glaucoma.

Authors:  Aruj K Khurana; Bhawna Khurana; Ashok K Khurana
Journal:  J Curr Glaucoma Pract       Date:  2012-10-16

Review 6.  Drug-induced Acute Angle-closure Glaucoma: A Review.

Authors:  Michael C Yang; Ken Y Lin
Journal:  J Curr Glaucoma Pract       Date:  2019 Sep-Dec

7.  The Multispecialty Toxin: A Literature Review of Botulinum Toxin.

Authors:  Karen Bach; Richard Simman
Journal:  Plast Reconstr Surg Glob Open       Date:  2022-04-06

Review 8.  A review of drug-induced acute angle closure glaucoma for non-ophthalmologists.

Authors:  Elliott Yann Ah-Kee; Eric Egong; Ahad Shafi; Lik Thai Lim; James Li Yim
Journal:  Qatar Med J       Date:  2015-05-10

9.  Acute angle closure following periorbital botulinum toxin injection in a patient with retinitis pigmentosa.

Authors:  Jen-Chia Tsai
Journal:  Taiwan J Ophthalmol       Date:  2017 Apr-Jun
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.